Capital Flow Monitor · Sponsors · CIK 1696341
AVAVA, Inc.
275 SECOND AVENUE, WALTHAM, MA, 02451 · 617-912-2680
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$38.0M
Sold
$19.6M
% sold
51.6%
Investors
59
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-04 | D ·current | 506(b) | $38.0M | $19.6M | 51.6% | 59 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Clinton Earl Carnell Jr. — Executive Officer / Director, Waltham, MA
-
Mary Fisher — Director, Waltham, MA
1 other raise
- Dermata Therapeutics, Inc. $4.1M of $4.1M · 100.0%
-
Daniel Browne — Director, Waltham, MA
1 other raise
- Yuva Biosciences, Inc. $1.1M of $3.0M · 37.3%
- Richard Rox Anderson — Director, Waltham, MA
- Jay Bhawalkar — Executive Officer, Waltham, MA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.